PhRMA Says FDA Coupon Study Oversteps Price Regulation Boundaries

The Pharmaceutical Research and Manufacturers of America is concerned that FDA's plans to study the impact of coupons embedded in print ads on consumer perceptions is beyond the scope of the agency's authority